CORE HEALTHCARE

PRESENTED BY
ARUN JOSHI NITIN MISHRA VIKRANT ARORA

LEARNING
Learning is a relatively permanent change in the person acquired through practice.

NATURE OF LEARNING
A change in behavior Relatively permanent Comes through practice or experience

CORE HEALTHCARE
Founded in 1988 in Ahmedabad & known as Core Parenteral Ltd. Growth of turnover of Rs. 21.7 million to Rs. 2610 million & from 30 to 3000 employees

within 9 years i.e from 1988 to 1996.

CURRENT SCENARIO
Capacity of producing 600 million units of IV fluids, 2.5 billion ampoules of SVPs, 2.75 billion units of

syringes, 1.5 billion tablets, 15 million bottles of

formulation per annum. Country & worldwide distribution & over 5000 distributors & stockists in India.

CURRENT SCENARIO
Assets of Rs. 3 billion & market capitalization of around Rs. 10 billion.

REASONS OF SUCCESS
Better quality products, state-of-art technology, excellent marketing strategy, reduced cost of products, following work ethics, zero bacteria products & untouched by

hand products, delivering international quality.

PARENTERALS TO HEALTHCARE
Only IV Fluids manufacturer till early 1990s. Addition of new products like parenteral nutrition,

blood products, pharmaceuticals, surgical products,

medical disposables like syringes etc. Changed its name from Core Parenterals to CHL Ltd. In 1994.

BUSINESS PHILOSOPHY
Emotional pharmacopeia. Producing the best in quality products. Dealing in India as well as Internationally. Producing only cost efficient products.

HUMAN RESOURCES DEVELOPMENT

Young and Qualified Persons Enjoyable Environment Job Rotation Different Learning Programs

TRAINING AND DEVELOPMENT

Different and Innovative Training programs In 1995-96 Co. invested 15,221 man days in HRD

Roles Models from Indian mythology like

Ekalavya Inspiring names of Training halls.

TRAINING AND DEVELOPMENT

Interesting Programs Pussy-cat salesman to tiger salesman Develop all-round ground dynamism like Maradona

LATEST ADDITION

Vishwakarma Training Program

INTERNATIONAL OPERATIONS
International presence in more than 63 countries. Strong quality equity helped in reducing time lag for launching new products. Working towards setting up a strong international distribution and marketing network.

AWARDS
Won the prestigious IDMA award for manufacturing facility for IV fluids. Received the ISO 9002 approval from BVQI, London for the same facility. Also certified from GMP(good manufacturing practices) as per norms set by WHO.

NEW COMPETITIVE REALITIES

Competitors in international markets are BAXTER(worlds largest manufacturer)and

BECTON DICKINSON(BD, that was into blood

transfusions and disposal syringes). Absence of experienced top management as well as middle management.

NEW COMPETITIVE REALITIES

The early first mover advantage were being equaled or surpassed by every large-scale manufacturer. Dealers and distributors are relatively more powerful then late 1980s.